ABSTRACT
Studies of the use of artificial agents and robots to solicit donations from people have suggested that the design of the agents must consider facial expressions. However, there has not been sufficient evidence to generalize the finding that the emotions conveyed by agents' facial expressions can induce donations. In the present study, we conducted an experiment with an animated character that has intermediate realism and a different appearance from those in previous studies to replicate the finding that facial expressions represented by changes in the shapes of the eyes and mouth cause people to become more prosocial and to test whether we can extend this finding to the emotional expressions presented by changes in the dynamic properties of eyes. In the experiment, participants ([Formula: see text]) played a hypothetical dictator game with an avatar that expressed its emotions by changing the shapes of its eyes, eyebrows and mouth and by changing the frequency of eye blinking. The results showed that the emotions expressed by changes in the shape of the facial parts contributed to eliciting a higher donation amount, consistent with previous studies. However, we could not find an additive effect of the emotional expression shown by eye blinking. The results suggest that, regardless of appearance, emotional expression is useful in the design of a virtual agent's face, but it might not be necessary to consider the dynamic properties of the eyes.
Subject(s)
Blinking/physiology , Facial Expression , Helping Behavior , Adult , Emotions , Female , Humans , Male , Middle Aged , User-Computer InterfaceABSTRACT
Unbiased transcriptome profiling and functional genomics approaches have identified ubiquitin-specific protease 40 (USP40) as a highly specific glomerular transcript. This gene product remains uncharacterized, and its biological function is completely unknown. Here, we showed that mouse and rat glomeruli exhibit specific expression of the USP40 protein, which migrated at 150 kDa and was exclusively localized in the podocyte cytoplasm of the adult kidney. Double-labeling immunofluorescence staining and confocal microscopy analysis of fetal and neonate kidney samples revealed that USP40 was also expressed in the vasculature, including in glomerular endothelial cells at the premature stage. USP40 in cultured glomerular endothelial cells and podocytes was specifically localized to the intermediate filament protein nestin. In glomerular endothelial cells, immunoprecipitation confirmed actual protein-protein binding of USP40 with nestin, and USP40-small-interfering RNA transfection revealed significant reduction of nestin. In a rat model of minimal-change nephrotic syndrome, USP40 expression was apparently reduced, which was also associated with the reduction of nestin. Zebrafish morphants lacking Usp40 exhibited disorganized glomeruli with the reduction of the cell junction in the endothelium and foot process effacement in the podocytes. Permeability studies in these zebrafish morphants demonstrated a disruption of the selective glomerular permeability filter. These data indicate that USP40/Usp40 is a novel protein that might play a crucial role in glomerulogenesis and the glomerular integrity after birth through the modulation of intermediate filament protein homeostasis.
Subject(s)
Glomerular Filtration Rate , Kidney Glomerulus/enzymology , Ubiquitin Thiolesterase/metabolism , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Animals, Genetically Modified , Disease Models, Animal , Down-Regulation , Endothelial Cells/enzymology , Gene Expression Regulation, Developmental , Gene Expression Regulation, Enzymologic , Gene Knockdown Techniques , Genotype , HEK293 Cells , Humans , Kidney Glomerulus/embryology , Kidney Glomerulus/pathology , Kidney Glomerulus/physiopathology , Mice , Nephrosis, Lipoid/enzymology , Nephrosis, Lipoid/genetics , Nephrosis, Lipoid/physiopathology , Nestin/metabolism , Permeability , Phenotype , Podocytes/enzymology , RNA Interference , Rats , Transfection , Ubiquitin Thiolesterase/genetics , Zebrafish/embryology , Zebrafish/genetics , Zebrafish Proteins/geneticsABSTRACT
Although podocyte damage is known to be responsible for the development of minimal-change disease (MCD), the underlying mechanism remains to be elucidated. Previously, using a rat MCD model, we showed that endoplasmic reticulum (ER) stress in the podocytes was associated with the heavy proteinuric state and another group reported that a mammalian target of rapamycin complex 1 (mTORC1) inhibitor protected against proteinuria. In this study, which utilized a rat MCD model, a combination of immunohistochemistry, dual immunofluorescence and confocal microscopy, western blot analysis, and quantitative real-time RT-PCR revealed co-activation of the unfolded protein response (UPR), which was induced by ER stress, and mTORC1 in glomerular podocytes before the onset of proteinuria and downregulation of nephrin at the post-translational level at the onset of proteinuria. Podocyte culture experiments revealed that mTORC1 activation preceded the UPR that was associated with a marked decrease in the energy charge. The mTORC1 inhibitor everolimus completely inhibited proteinuria through a reduction in both mTORC1 and UPR activity and preserved nephrin expression in the glomerular podocytes. In conclusion, mTORC1 activation may perturb the regulatory system of energy metabolism primarily by promoting energy consumption and inducing the UPR, which underlie proteinuria in MCD.